This study investigated a combined approach of a persulfate-based advanced oxidation process (AOP) followed by biological treatment of a textile industrial effluent. The effluent from the textile industry is primarily composed of various dyes in varying concentrations, resulting in high chemical oxygen demand (COD) and biological oxygen demand (BOD). The model pollutant rhodamine B (RhB) was used in the optimization studies. During the persulfate oxidation process (PSO), persulfate activation is required to generate sulfate radicals (SO ). Raw laterite soil was used as a catalyst for the treatment of RhB in batch studies, and it was able to reduce the dye concentration by about 20% in 60 min of operation, with initial RhB concentrations of 150 mg L and persulfate concentrations of 200 mg L. Furthermore, alkali-treated laterite soil (ATLS) was used as a catalyst, achieving 57%-60% removal in 60 min at pH 3 and complete removal after 72 h of biological treatment. Furthermore, the optimized conditions were tested on real field waters to determine efficiency, and it was observed that the PSO removed approximately 45% of COD, with further biological treatment for 72 h increasing the removal efficiency to 64%. All other parameters of water quality were reduced by more than 60%.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11865458PMC
http://dx.doi.org/10.1155/abb/9325665DOI Listing

Publication Analysis

Top Keywords

biological treatment
16
advanced oxidation
8
treatment textile
8
textile industrial
8
industrial effluent
8
oxidation process
8
oxygen demand
8
cod biological
8
laterite soil
8
biological
5

Similar Publications

Objectives: Our study aimed to identify potential predictors for additional systemic involvement in patients with noninfectious uveitis, specifically focusing on their demographic, etiological, clinical, and laboratory data features from the pediatric rheumatology perspective.

Methods: Patients with noninfectious uveitis before the age of 18 years and followed up for at least 3 months in 2 tertiary centers of pediatric rheumatology and ophthalmology departments were included in the study. Demographics, etiology, clinical features, laboratory data, and treatments administered were evaluated and compared based on the etiology (idiopathic and systemic disease-related uveitis [SD-U]) and the use of biologic disease-modifying antirheumatic drugs.

View Article and Find Full Text PDF

The human genome project ushered in a genomic medicine era that was largely unimaginable three decades ago. Discoveries of druggable cancer drivers enabled biomarker-driven gene- and immune-targeted therapy and transformed cancer treatment. Minimizing treatment not expected to benefit, and toxicity-including financial and time-are important goals of modern oncology.

View Article and Find Full Text PDF

Better Together: Implementation of a Public Health Learning Community During the COVID-19 Pandemic.

Am J Public Health

April 2025

Kristen M. Brown, Brigette Courtot, Zara Porter, and Sofia Hinojosa are with the Health Policy Center, Urban Institute, Washington, DC.

The Centers for Disease Control and Prevention's Partnering for Vaccine Equity program was developed during the COVID-19 public health emergency to fund more than 500 community-based organizations working to improve vaccine equity. Organizations were supported by a virtual learning community where members received tailored learning content, peer-to-peer learning opportunities, and resources that facilitated deployment of vaccine-related programming during a dynamic pandemic. Process evaluation metrics indicate successful implementation of the learning community.

View Article and Find Full Text PDF

Psoriatic arthritis (PsA) is a chronic, inflammatory disease with heterogeneous clinical features. The pathogenesis of PsA involves a complex interplay of genetic, immunologic, and environmental factors, leading to the activation of the immune system and subsequent inflammation. Over the past decade, the understanding of the immune mechanisms underlying PsA has advanced significantly, particularly regarding the role of the interleukin-23/T helper 17 pathway in the disease process.

View Article and Find Full Text PDF

Background: COVID-19 still poses a major public health challenge worldwide and vaccination remains one of the major interventions to control the disease. Different types of vaccines approved by the World Health Organization (WHO) are currently in use across the world to protect against the disease. This study assessed the prevalence and pattern of adverse events following immunization (AEFI) after receiving COVID-19 vaccine (the Oxford-AstraZeneca vaccine) among the adult population in Sokoto metropolis, North-west, Nigeria.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!